.... .... .... .... .... .... .... .... .... .... .... .... .... .... .... .... .... ....
Justin Crowe, founder and CEO of Parting Stone in Santa Fe, pictured in 2019. The company take human and pet remains and turns them into solidified remains. (Eddie Moore/Albuquerque Journal)
ALBUQUERQUE, N.M. Santa Fe-based Parting Stone’s novel technology to turn cremated ashes into beautiful, solidified remains is rapidly gaining ground in the “deathcare” industry.
The company, which launched in fall 2019, offers people a better way to connect with departed loved ones, turning ashes into smooth, polished memorial stones that can be held, shared or displayed, said Parting Stone founder and CEO Justin Crowe.
The company now partners with 340 funeral homes across the country to offer solidification services to families who plan to create remains. That’s up from about 200 funeral partners last fall.
Avisa Diagnostics Begins Trading on the Canadian Securities Exchange
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
Share:
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
SANTA FE, N. M., May 04, 2021 (GLOBE NEWSWIRE) Avisa Diagnostics Inc. (formerly, FogChain Corp.) (the Company ) is pleased to announce the closing of its previously announced reverse takeover transaction (the Transaction ) with Avisa Pharma Inc. ( Avisa ). In accordance with the merger agreement and plan of reorganization dated February 1, 2021 (the Merger Agreement ), which superseded and replaced the previously announced Letter of Intent dated January 12, 2021, the Transaction was effected by way of a triangular merger between the Company, Avisa, and a wholly owned, Delaware subsidiary of the Company ( Subco ) pursuant to the laws of the State of Delaware. The combined public company resulting from the Transaction (the Resulting Issuer ) will carry on the business of Avisa.
FogChain Announces Shares For Debt Settlement
FogChain Corp. announces that the Company intends to settle a total of $85,000 of debt owed to an administrative services provider of the Company, through the issuance of an aggregate of 1,545,454 common shares of the Company at a deemed price of $0.055 per Debt Share . All the Debt Shares issued in connection with the Debt Settlement are subject to a statutory hold period of four months plus a day from the date …
FogChain Corp. (CSE: FOG.X) (OTCB: FOGCF) (FRA: MUU3) (the ” Company ” or ” FogChain “), announces that the Company intends to settle a total of $85,000 of debt (the ” Debt “) owed to an administrative services provider of the Company, through the issuance of an aggregate of 1,545,454 common shares of the Company (the ” Debt Shares “) at a deemed price of $0.055 per Debt Share (the ” Debt Settlement “).
(CSE: FOG.X) (OTCB: FOGCF) (FRA: MUU3) (the
Company or
FogChain ) is pleased to announce, further to its news release dated January 13, 2021, the Company has entered into a merger agreement and plan of reorganization (the
Definitive Agreement ) with Avisa Pharma Inc. (
Avisa ) and FogChain USA Inc., a wholly-owned subsidiary of FogChain, dated February 1, 2021, in respect of a statutory merger under the Delaware General Corporation Law pursuant to which the Company has agreed to acquire all of the issued and outstanding shares in the capital of Avisa (the
Avisa Shares ), a privately held Delaware company, in exchange for the issuance of approximately 33,263,123 common shares and 14,825,786 restricted voting shares in the capital of the Company (the
vimarsana © 2020. All Rights Reserved.